US device industry concedes initiative in gainsharing arrangements
This article was originally published in Clinica
Executive Summary
The US device industry appears to have lost its battle to stop Congress from sanctioning gainsharing arrangements. As Clinica went to press, the US Senate was poised to vote on a massive deficit reduction package that included a Medicare gainsharing demonstration project at six different sites. The 2006 Deficit Reduction Act would reduce projected spending growth by $40bn over five years out of a projected $12.7 trillion - the first time that Congress has tried to curb escalating budgets under President Bush and healthcare spending is a significant target in the bill.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.